YIELD10 BIOSCIENCE,INC. (NASDAQ:YTEN) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On December 27, 2017, Yield10 Bioscience, Inc. (the “Company”) filed a Certificate of Amendment (the“Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference, with the Secretary of State of the State of Delaware. The Certificate of Amendment, effective as of December 27, 2017, decreases from 250,000,000 shares to 40,000,000 shares the aggregate number of shares of the Company’s common stock that are authorized to be issued.
As described below, the Company's stockholders approved the amendment at a special meeting held on December 27, 2017.
Item 5.07 – Submission of Matters to a Vote of Security Holders.
On December 27, 2017, the Company held a special meeting of its stockholders (the “Special Meeting”).
At the Special Meeting, of the 3,461,714 shares of the Company’s common stock entitled to vote, 2,486,316 shares were represented at the meeting in person or by proxy, constituting a quorum. The voting results relating to the proposed amendment to the Certificate of Incorporation are as set forth below. This proposal is described in further detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on October 17, 2017.
The stockholders approved the proposal authorizing an amendment to the Certificate of Incorporation to decrease from 250,000,000 shares to 40,000,000 shares the aggregate number of shares of the Company’s common stock that are authorized to be issued.
Votes For |
Votes Against |
Votes Abstain |
1,965,925 |
508,028 |
12,363 |
Item 5.07 Financial Statements and Exhibits.
(d)Exhibits.
Exhibit |
|
No. |
Description |
3.1 |
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Yield10 Bioscience, Inc. |
YIELD10 BIOSCIENCE, INC. ExhibitEX-3.1 2 exhibit31122717.htm EXHIBIT 3.1 Exhibit Exhibit 3.1CERTIFICATE OF AMENDMENTOFAMENDED AND RESTATED CERTIFICATE OF INCORPORATIONOFYIELD10 BIOSCIENCE,…To view the full exhibit click here
About YIELD10 BIOSCIENCE,INC. (NASDAQ:YTEN)
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.